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Summary: There are at least three stages in the targeting of soluble lysosomal enzymes: transfer of N-
acetylglucosaminyl l-phosphate to high-mannose oligosaccharide side chains, removal of N-acetylglucosamine
and recognition of the "uncovered" mannose 6-phosphate residues. Defects in the transfer reaction cause
mucolipidoses II and III. Those in the subsequent stages of the targeting may result in similar clinical disorders.
To differentiate between possible defects of the targeting in cultured cells we have developed a procedure for
a combined detection of the phosphorylation, uncovering of the transferred phosphate residues and the
targeting of lysosomal enzymes. For this purpose cultured cells are metabolically labelled with [32P]phosphate
and a lysosomal enzyme, such äs cathepsin D, is isolated from the labelled cells and the medium by
immunoprecipitation. The immunoprecipitates are dissolved with sodium dodecylsulphate and incubated in
the presence and absence of calf intestine alkaline phosphatase. We show that the treatment of the denatured
protein results in hydrolysis of phosphomonoester groups and that the phosphodiester and the peptide bonds
remain intact. The initial and the residual radioactivity associated with the lysosomal enzyme which represent
the total phosphate and the phosphodiester groups, respectively, are determined by gel-electrophoresis,
fluorography and densitometry. This procedure extends one of the previously established methods for the
diagnosis of mucolipidoses II and III.
Introduction phosphodiester -N-acetylglucosaminidase1). Partial
_ . , ,, t , - , or complete deficiencies in the activity of N-acetyl-
The targeting of Soluble lysosomal enzymes depends lucosami , j.phosphotransferase cause mucolipi-
on the acquisiüon of mannose 6-phosphate groups doses ffl and tiyd (4 5) A defici in
(reviewed m 1. c. (l --3)). These groups are synthesized ^ uncoveri enz^me is Ukel to cause a phenotype
on high-mannose oligosaccharide side chains of so!- ^^ mucoli idosis m (6)
üble lysosomal enzymes and activator protems in two
Steps. In the first step, N-acetylglucosaminyl l- In a combination with immunoprecipitation, gel-elec-
phosphotransferase1) yields a phosphodiester and in trophoresis and fluorography, metabolic labelling has
the second 'Step the phosphodiester is hydrolysed by been used successfully for screening of the phospho-
the "uncovering" enzyme, N-acetylglucosamine l- transferase activity in cultured mucolipidosis II or III
cells (7). In this assay both the labelling and the
Enz meg distribution of a lysosomal enzyme between cells and
N-Acetylglucosamine l-phosphodiester N-acetylglucosami- medium are determined so that defects in either the
nidase (EC 3.1.4.45) phosphorylation or targeting can be recognized. We
Alkalme pl^sphatase^C 3.1.3.1) argued that the ,abe,ling foHowed by immunoprecip-
v^ainepsin \j \c\^ J.^T.^J. jj t % \ e+ i i i jN-Acetylglucosaminyl phosphotransferase (EC 2.7.8.17) itation, gel-electrophoresis and fluorography should
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bc useful for simultaneously and differentially deter-
mining the phosphodiester and phosphomonoester
groups, provided thal the latter could be efficiently
and specifically removed from the immunoprecipi-
tated enzymes by a phosphatase. In addition to phos-
phorylation, such a determination would also reveal
defects in the uncovering. We elaborated the experi-
mental conditions for this determination using calf
intestine alkaline phosphatase, which is commercially
available, and U937 cells, which are a relatively rieh
source of cathepsin D. From this enzyme we also
isolated phosphorylated oligosaccharides in an
amount sufficient for the Separation and quantitation
of their phosphomono- and diester forms by ion ex-
cbange chromatography (8) and scintillation count-
ing. The ratio of the radioactivity in these oligosac-
charides confirmed the value which was determined




Human U937 (l ,25-dihydroxiferolcalcitriol ihydrox(l,25-
dihydroxferolpromonocytes (9) vvere cultured in RPMI 1640
medium and treated with l O""7 mol/1 (1,25-dihydro-
xycholecalciferol) s previously described (10). The treatment
resulted in an increased expression of cathepsin D.
Metabolie label l ing
In studies on glycopeptide labelling, cells grpwn to a density of
5 — 10 χ 108/1 were collected by centrifugation, washed and
subjected to metabolic labelling s described previously (11),
except that RPMI 1640 medium was used. The labelling me-
dium was free of either methionine or phosphate and contained
1.3 GBq/l [35S]methionine or 3.7-7.4 GBq/1 [32P]phosphate.
The phosphate was carrier-free and the methionine had a spe-
cific activity of 50 TBq/mmol. The radioactive chemicals were
purchased from Amersham-Buchler, Braunschweig, Germany.
In pulse-chase experiments with [35S]methionine the labelling
was performed for 24 h and terminated by adding a concen-
trated solution of methionine to a final concentration of 10
mg/1.
Immunoprec ip i ta t ion
The cells were collected by centrifugation and taken up in l ml
of a detergent mixture containing 10 ml/l Triton X-100, 5 g/l
Na deoxycholate, l mmol/1 MgCl2, 5 mmol/1 iodoacetamide,
l mmol/1 phenylmethanesulphonyl fluoride, 20 mg/1 DNase I,
0.14 mol/1 NaCl, 10 mmol/1 Na phosphate, pH 7.4. After
centrifugation the medium was mixed with 0.2 ml of five-fold
concentrated stock solution of the detergent mixture. The sam-
ples were subjected to freeze-thawing and centrifugation at
40 000 £ for l h. The supernatants were mixed with affinity
purified rabbit anti-human cathepsin D (20 μg per aliquot
corresponding to 5 χ l O5 cells) and goat anti-rabbit immuno-
globulin conjugated to Eupergit C1Z (0.5 μg second antibody
per μg first antibody). Eupergit C1Z was purchased from
Roehm Pharma, Weiterstadt, Germany. The samples were ro-
tated end-over at 4 °C overnight. The immunoprecipitates were
collected by centrifugation and washing s deseribed elsewhere
(12).
Treatmenl of immunoprecipi ta tes with alkaline
phosphatase
The washed immunoprecipitales were solubilized by heating at
95 °C for 5 min with 50 μΐ 6 g/l SDS, 60 mmol/1 Tris-HCl, pH
8.8. The Suspension was diluled with 105 μΐ Η2Ο and centri-
fuged. The supernatant was divided into 50 μΐ aliquots, which
were mixed with 2.5 μΐ of various dilutions of calf intestine
alkaline phosphatase in the same buffer s supplied from Boeh-
ringer-Mannheim. Under Standard coriditions the incubations
were performed with 0, 6.2 and 12.5 units enzyme (catalogue
No. 567744) for 24 h at 37 °C. The incubations were terminated
by adding 25 μΐ 28 g/l SDS, 28 mmol/1 dithiothreitol, 80 ml/l
glycerol, 0.35 mol/1 Tris-HCl, pH 6.8 and heating. The com-
pleteness of the digestion was determined by cornparing the
results of the two incubations with the increasing amounts of
the erizyme; the results were the same when a purer enzyme
preparation (catalogue No. 713023) was used.
A rather high amount of calf intestine alkaline phosphatase
was needed to achieve complete cleavage of mannose 6-phos-
phate residues in lysosomal enzymes. Under our incubation
conditions, mannose 6-phosphate (10 mmol/1) exerted a weak
probably competitive Inhibition (28%) of the hydrolysis of 5.5
mmol/1 4-nitrophenyl phosphate. In choosing the buffer we
took into consideration its compatibility with the subsequent
analysis in polyacrylamide-gel electrophoresis. SDS, which was
used to solubilize the immunoprecipitate, stimulated hydrolysis
of 4-nitrophenyl phosphate. In the concentration r nge 1 — 10
g/l SDS the activity was increased 1.7 to 2-fold.
Separation and quant i f icat ion of radioactive gly-
copeptides
After the above treatments, the immunoprecipitates were sub-
jected to polyacrylamide-gel electrophoresis in the presence of
SDS with 131 g/l acrylamide in the separating gel s described
previously (11). The radioactivity was visualized by fluoro-
graphy (13) and quantified by densitometry using an Ultroscan
densitometer from LKB-Pharmacia, Freiburg, Germany. Tung-
sten screens "Lightning plus" from Du Pont de Nemours, Bad
Nauheim, Germany, were used for detection of 3?P. The radio-
active Standards were prepared by incubating [14C]KCNO
with cytochrome c (MT = 12300), carbonic anhydrase (Mt
= 30 000), ovalbumin (M, = 46 000), bovine serum albumin
(Mc = 69000) and phosphofylase b (Mr = 97400) and dialysis.
Isolation and characterization of oligosaccharides
l χ l O6 calcitriol-treated U937 cells were labelled for 24h in
1.1 ml medium containing 9.3 MBq [32P]phosphate and 10
mmol/1 NH4C1. Cathepsin D was precipitated from cells and
medium. An aliquot of 20% of the immunoprecipitate was used
for the Standard treatments without and with alkaline phos-
phatase and 80% was subjected to polyacrylamide gel electrO"
phoresis for the Isolation of cathepshi D precursor. Following
fluorography the gel area ( 5 x 9 mm) containing the precursor
was cut out, soaked for 2 h in 0.1 ml 60 mmol/1 Na acetate,
5 mmol/1 Na phosphate, pH 5.3, crushed with a pestle arid
incubated with l mU endo- ^N-acetylglucosaminidase H
(Boehringer-Mannheim) for 7 h at 37 °C. Then 0.1 ml 60 mmol/1
Na acetate and l mU enzyme were added and the incubation
was continued for 24 h. The hydrolysed material was collected
in 0.4 ml acetate buffer, concentrated by lyophilization and
desalted in a spun Sephadex G-10 (LKB-Phamacia) cohirnn in
20 mmol/1 NaCl. The radioactive material was aliquoted and
one half was hydrolysed at pH 3 (14). Both.samples were dried,
dissolved in 40 μΐ 50 mrnol/1 Tris-HCl, pH 9.0; and halved to
be further incubated without or with 4 μ& alkaline phosphatase
for 20 h at 37 °C. The samples were diluted with l .4 ml 2 mrnol/l
ammonium acetate, pH 5.3 and applied to 0.5 χ 4 cm QAE-
Sephadex A-25 columns that were equilibrated with 2 mmol/1
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ammonium acetalc (8). The elulion was pcrformed in 0.5 ml
fractions by increasing the concentration of the buffer by
7 mmol/1 at each Step. The radioactivity was determined in a
liquid scintillation spectrophotometer.
Results
Label l ing of cathepsin D with [32P]phosphate
and selective cleavage of phosphomono-
ester residues
We developed a new procedure differentiating be-
tween "covered" and "uncovered" phosphate residues
in a lysosomal enzyme according to the scheme shown
in figure l. Several experiments controlling the relia-
bility of this method are described below.
When cathepsin D was isolated from calcitriol-treated
U937 cells after metabolic labelling with
[32P]phosphate, the radioactivity was found in the
precursor, intermediate, large mature and small ma-
ture polypeptides (flg. 2, lane 1). In the medium the
radioactivity was found in the precursor polypeptide
(fig. 2, lane 7). A small amount of the radioactive
large mature polypeptide was also present and prob-
ably represented a release froni differentiated or from
dead cells. The radioactivity associated with the dif-
ferent polypeptides of cathepsin D was present in their
carbohydrate moieties, s indicated by removal of all
the label with glycopeptidase F (not shown).
Depending on the polypeptide, a characteristic pro-
portion of phosphate residues were resistant to phos-
phatase even in the presence of an excess of the
^J?— Biosynthesis and labelling
DD-(P)-GnAc 4> ίΐ^ΓΚίΡ)
Immunoprecipitation and aliquoting
Phosphatase FI Incubation J+l Phosphatase
SnAc
Gel electrophoresis and fluorography
Fig. 1. Scheme depicting the principle of the labelling of, and
differentiation between the total and covered phosphate
residues in carbohydrate side chains in a lysosomal
enzyme. The reactions l and 2 denote the two Steps in
the biosynthesis of mannose 6-phosphate residues cat-
alysed by Nracetylglucosarninylphosphotransferase and
N-acetylglucosamirie l-phosphodiester N-acetylglucos-
aminidase.
L. E. = lysosomal enzyme; P = radioactive phosphate
residue; GnAc = N-acetylghicosamine. The quantita-
tion of the labelled forms of the enzyme is indicated by
the rectangular areas.
hydrolase. With isolated oligosaccharides it was found
that this proportion represented phosphodiester
groups (see below). The proportion was the same
when alkaline phosphatase preparations dedicated for
either enzyme-linked immunoassays or molecular bio-
logy were used (fig. 2). The phosphodiester groups
were more abundant in the precursor than in the























Lane 1 2 3 4 5 6 7 8 9 10 11 12 13
Fig. 2. Digestion of 32P-labelled cathepsin D frora calcitriol-
treated U937 cells and medium with various amounts
of alkaline phosphatase. The cells were labelled with
[32P]phosphate for 24 h. Aliquots of the immunoprecip-
itates of cathepsin D were incubated for 30 h at 37 °C
with various amounts of alkaline phosphatase s indi-
cated. A and B refer to calf intestine alkaline phospha-
tase catalogue Nos. 567744 and 713023, Boehringer-
Mannheim, respectively. Radioactivity in the samples
was analysed by SDS polyacrylamide gel electrophoresis
and fluorography. The positions of the precursor (P),
intermediate (I), large mature (LM) and small mature
(SM) polypeptides of cathepsin D are indicated.
The removal of phosphate residues from cathepsin D
glycopeptides was not due to a proteolytic digestion
of the latter. Indeed, treatment of [35S]methionine-
labelled glycopeptides did not significantly change the
intensity or apparent size of the precursor, interme-
diate or large mature glycopeptides of cathepsin D
(fig. 3). This was not a trivial finding because treat-
ment of the denatured labelled cathepsin D with an
alkaline phosphatase from Escherichia coli resulted in
degradation of the polypeptides (not shown). The
small mature glycopeptide was well detected only in
immunoprecipitates from calcitriol-treated cells, and
its mobility was partially retarded following the treat-
ment (fig. 3, laues 7 — 9). It had been noticed earlier
that the mobility of the small glycopeptide depended
on the composition of its carbohydrate side chain
(15).
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Fig. 3. Effect of alkaline phosphatase pn the electrophoretic
mobility of [35S]methionine-labelied cathepsin D poly-
peptides. Control and calcitriol-treated U937 cells were
subjected to a 25h-pulse and 16h-chase metabolic la-
belling with [35S]methionine. Cathepsin D was immu-
noprecipitated frora cell and medium extracts and ali-
quots of the immunoprecipitates were incubated with-
out and with alkaline phosphatase using the Standard
conditions. The labelled polypeptides were separated by
SDS polyacrylamide gel electrophoresis and visualized
by fluorography (see legend of fig. 2 for the Symbols).
Calf intestine alkaline phosphatase is less active with
mannose 6-phosphate than with 4-nitrophenyl phos-
phate. However, the phosphatase is activated in the
presence of SDS, and it is possible to remove the
phosphomonoester groups from denatured lysosomal
enzymes if a relatively high ampunt of the phospha-
tase is used. According to our experience the method
is applicable to a- and ß-chains of ß-hexosaminidase
and to oc-glucosidase after immunoprecipitation from
metabolically labelled fibroblasts (not shown). It can
also be used with arylsulphatase A (Dr. V. Gieselmann,
personal communication) and probably many other
lysosomal enzymes.
Proportion of the phosphomonoester and
phosphodiester groups in isolated oligo-
saccharides
From the data presented so far we concluded that a
prolonged treatment with the commercial alkaline
phosphatase was adequate to ensure a selective, com-
plete hydrolysis of phosphomonoester groups in
[32P]phosphate-labelled cathepsin D, with the conser-
vation of phosphodiester groups. To further validate
this conclusion, we isolated carbohydrate side chains
from the labelled cathepsin D and fractionated the
oligosaccharides in a QAE-Sephadex A-25 column.
The radioactivity separated into three major peaks
that were eluted at 60, 90 and 210{mmol/l ammonium
acetate (fig. 4). By analogy to the Separation reported
by Lazzarino & Gabel (8) the material present in peak
I was supposed to contain a phosphodiester, peak II
a phosphomonoester and peak III two phosphomono-
ester groups. This tentative assignment was cofirmed




Fig. 4. Characterization of 32P-labelled oligosaccharides from
cathepsin D. Calcitriol-treated U937 cells were meta-
bolically labelled with [32P]phosphate in the presence of
10mmol/l NH4C1 and the secreted cathepsin D was
immunoprecipitated. Oligosaccharides were isolated
from 80% of the material using endoglucosaminidase
H, and aliquots were treated with either mild acid,
alkaiine phosphatase (-l· AP) or both äs described in
Materials and Methods. The oligosaccharides were sep-
arated on QAE-Sephadex A-25 and the radioactivity in
the fractions was determined.
A: Separation of oligosaccharides without treatment (o)
or after incubation with alkaline phosphatase (o); In
the untreated sample the radioactivity was separated
into three main peaks. The sum of the radioactivity in
fractions marked by the bars was set at 100%. The
remainder (20%) of the immunoprecipitate was ana-
lysed by the Standard procedure for sensitivity to al-
kaline phosphatase; the flüorogram of the radioactivity
in samples that were incubated without or with 6.2 units
(-f) and 12.5 units enzyme (+)· is shown in the inset.
B: The oligosaccharides were treated with mild acid:
one half was fractionated dkectly (o) and the other
after incubation with alkaline phosphatase (·).
. f
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i) the material present in peak I but not in peaks II
and III was resistant to alkaline phosphatase;
ii) material in peak I but not in peaks II and III was
sensitive to mild acid hydrolysis;
iii) treatment of the oligosaccharides with alkaline
phosphatase converted a large proportion of the ra-
dioactivity associated with peaks II and III to a prod-
uct with the Chromatographie mobility of inorganic
phosphate, and it was eluted at 170 mmol/1 ammo-
nium acetate, and
iv) a complete conversion of the radioactivity to free
phosphate was observed only if the oligosaccharides
were subjected to mild acid hydrolysis prior to the
treatment with alkaline phosphatase.
In control samples the sum of the radioactivity present
in peaks I and II was less than in peak III, while
following the mild acid treatment the proportions
were reversed. It is likely thäf some of the radioactivity
was associated with phosphorylated hybrid oligosac-
charides. These were expected to fractionate between
1 peaks II and III or within peak III. In mild acid
! hydrolysis these oligosaccharides should be converted
. to phosphomonoester-containing oligosaccharides
and be recovered in peak II.
Of the radioactivity present in cathepsin D that was
immunoprecipitated from the NH4Cl-elicited secre-
tion, 14—18% resisted the treatment with alkaline
phosphatase (see inset in fig. 4a). Of the radioactivity
recovered in the three major oligosaccharide peaks
from the same cathepsin D preparation, 19% was
present in peak I, i.e. in the phosphatase-resistant
and mild acid-sensitive material. Therefore, the treat-
ment of solubiliZed immunoprecipitates with calf in-
testine alkaline phosphatase is adequate for discrim-
inating the relative contents of phosphomono·* and
phosphodiester groups in [32P]labelled cathepsin D,
Discussion
By metabplic labelliiig of cukured cells with radio-
active phosphate, immunoi$ölation of a labelled ly-
sosomal enzyme from cells and medium and deter-
mination of tbe uncovering ratio of, the phosphate
groups in this enzyme^ it is possible to determine three
Parameters Which are important for its targeting to
lysosomes. These parameters are
i) the efficiency of the phosphorylation,
ii) the efficiency of the retention of the phosphorylated
enzyme and
iii) the efficiency of the uncovering of its phosphate
residues.
In the present work we established the conditions for
the determination of the third parameter using com-
mercially available alkaline phosphatase. Under these
conditions only the phosphomonoester residues are
hydrolysed; the phosphodiester residues and the pro-
tein backbone remain intact.
Previously the uncovering of phosphate residues has
been determined by ion exchange chromatography of
isolated oligosaccharides (8). Unlike the present
method, this Separation distinguished oligosaccha-
rides containing a single phosphate residue from those
containing two. However, this Separation is arduous
and the sensitivity of the detection of the fractionated
oligosaccharides by scintillation counting is an order
of magnitude lower than that of the labelled polypep-
tides by screen-enhanced fluorography, which is ap-
prox. l Bq 32P.
With the new method small variations in the uncov-
ering of phosphate residues that are likely to occur
among different cell strains can be monitored. Using
this method we have observed that in fibroblasts the
uncovering is diminished and the rate of secretion of
cathepsin D with covered phosphate residues is en-
hanced if the cells are labelled in the presence of
NH4C1 (16). For the determination of the uncovering,
any well detectable phosphorylated lysosomal enzyme
can probably be used.
The efficiency of the uncovering and targeting of
lysosomal enzymes may play an important role in the
aetiology of mucolipidoses II and III. Alexander et
al. (6) reported a clinically normal individual with
elevated lysosomal enzyme activities in plasma. Fi-
broblasts from this individual contained approx. half
the normal N-acetylglucosamine l-phosphodiester N-
acetylglucosamidase. The uncovering ratio in lysoso-
mal enzymes from cells with a diminished activity of
this enzyme has not yet been examined. The activity
of the uncovering enzyme has been determined in very
few laboratories. The natural Substrates of this en-
zyme are difficult to prepare (17, 18) and it is not
clear if the alternative Substrate UDP-N-acetylglu-
cosamine (18) can universally be used. The formation
of the "recognition marker" by the two modifying
enzymes can be assayed indirectly with the help of
immobilized mannose 6-phosphate receptors (19).
However, this assay is handicapped by the limited
availability of the receptor and by the lack of discrim-
ination between ligands containing exclusively the
uncovered or a mixture of the uncovered and covered
phosphate residues.
The simplest biochemical diagnosis in mucolipidoses
II and III is performed by examining an elevation of
the activity of lysosomal enzymes in serum (20) or
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deficiency of the activity of lysosomal enzymes in
cultured fibroblasts or umniotic cells (21). An alter-
native is the determination of the activity of N-ace-
tylglucosaminyl phosphotransferase, but this is rather
laborious and has been performed in a few labora-
tories only. By measuring the activity of this enzyme
vvith a lysosomal enzyme and with -methyl manno-
side äs Substrate, a variant of mucolipidosis III may
be recognized in which the transferase has normal
catalytic activity but a low affinity to lysosomal en-
zymes (22, 23).
Until now all studied cases of mucolipidoses II and
III have been explained by a deficiency of the N-
acetylglucosaminyl phosphotransferase. This enzyme
is either completely or partially absent or inactive (4,
5, 7, 14, 24), or is unable to recognize lysosomal
enzymes (22, 23). The partial deficiencies with 3 to
30% residual activity usually correspond to mucoli-
pidosis III. However, the lower threshold may vary
depending on the ethnic origin of the patients and the
method usedun the enzyme assay. Okada et al. have
found up to 13% residual transferase activity in a
group of Japanese mucolipidosis II patients (24). In
their study no correlation between the residual phos-
phorylating activity and the clinical severity of the
disease could be established. It may be expected that
the clinical presentation of mucolipidoses II and III
mirrors not only the ability of the cells to phospho-
rylate but also to uncover and target the lysosomal
enzymes to lysosomes. In the prepent work we show
that the method of metabolic labelling of cells and
immunoisolation of lysosomal enzymes labelled with
[32P]phosphate, which has been used previously to
discriminate between mucolipidoses II and III (7), can
be easily extended to determine the uncovering ratiö
in both intracellular and seereted lysosomal enzymes.
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